Levo-norgestrel-nova-T and precancerous lesions of the endometrium.
The authors report the preliminary data on the topical treatment of endometrial hyperplasia by an intrauterine device releasing Levo-norgestrel (LNG-Nova-T), in a series of 31 patients. The patients examined so far by endometrial biopsies performed at predetermined intervals showed a complete histological regression of the hyperplasia, regardless of its pattern.
Scarselli
G
G
Department of Gynecology and Obstetrics, University of Florence, Italy.
Tantini
C
C
Colafranceschi
M
M
Taddei
G L
GL
Bargelli
G
G
Venturini
N
N
Branconi
F
F
D000287:Administration, Topical; D004714:Endometrial Hyperplasia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D009644:Norgestrel / Q000627:therapeutic use*; D011230:Precancerous Conditions / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D009644:Norgestrel